• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Device Problem Manufacturing, Packaging or Shipping Problem (2975)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/30/2022
Event Type  malfunction  
Event Description
It was reported that the drug on the balloon was missing.A ranger paclitaxel-coated pta 4.0mm x 40mm, 135cm balloon catheter was selected for endovascular therapy.During removal from the package, it was noticed that the drug on this device looked like it was missing.The device was not used, and the procedure was completed successfully.No reported patient complications.
 
Manufacturer Narrative
Device eval by manufacturer: the returned product consisted of a ranger drug coated balloon catheter with batch 01514h22.It was noted that the balloon protector was not present on the shipped device.Upon visual inspection, the drug coating was present throughout the distance between the gold marker bands.The coating appeared uniform and had a distinct white to whitish optical appearance.Despite being shipped without a balloon protector, analysis confirmed that the drug coating was present on the balloon and undamaged.
 
Event Description
It was reported that the drug on the balloon was missing.A ranger paclitaxel-coated pta 4.0mm x 40mm, 135cm balloon catheter was selected for endovascular therapy.During removal from the package, it was noticed that the drug on this device looked like it was missing.The device was not used, and the procedure was completed successfully.No reported patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15834216
MDR Text Key307584510
Report Number2124215-2022-47427
Device Sequence Number1
Product Code ONU
UDI-Device Identifier08714729975762
UDI-Public08714729975762
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P190019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/16/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number01514H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/08/2022
Initial Date FDA Received11/21/2022
Supplement Dates Manufacturer Received01/04/2023
Supplement Dates FDA Received01/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/16/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-